Ascelia Pharma AB (publ) (STO:ACE)

Ascelia Pharma AB Statistics

Total Valuation

STO:ACE has a market cap or net worth of SEK 402.61 million. The enterprise value is 353.72 million.

Market Cap	402.61M
Enterprise Value	353.72M

Important Dates

The next confirmed earnings date is Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:ACE has 133.54 million shares outstanding. The number of shares has increased by 110.07% in one year.

Current Share Class	133.54M
Shares Outstanding	133.54M
Shares Change (YoY)	+110.07%
Shares Change (QoQ)	+7.98%
Owned by Insiders (%)	5.39%
Owned by Institutions (%)	30.62%
Float	117.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	11.82
PS Ratio	n/a
PB Ratio	4.05
P/TBV Ratio	9.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.64
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.89

Financial Position

The company has a current ratio of 4.35, with a Debt / Equity ratio of 0.01.

Current Ratio	4.35
Quick Ratio	4.29
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-43.63

Financial Efficiency

Return on equity (ROE) is -85.48% and return on invested capital (ROIC) is -45.25%.

Return on Equity (ROE)	-85.48%
Return on Assets (ROA)	-36.64%
Return on Invested Capital (ROIC)	-45.25%
Return on Capital Employed (ROCE)	-74.47%
Weighted Average Cost of Capital (WACC)	9.43%
Revenue Per Employee	n/a
Profits Per Employee	-7.63M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-468,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.96% in the last 52 weeks. The beta is 0.89, so STO:ACE's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-1.96%
50-Day Moving Average	3.03
200-Day Moving Average	3.40
Relative Strength Index (RSI)	46.95
Average Volume (20 Days)	782,020

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-74.13M
Pretax Income	-76.72M
Net Income	-76.25M
EBITDA	-74.11M
EBIT	-74.13M
Earnings Per Share (EPS)	-0.67

Balance Sheet

The company has 49.86 million in cash and 970,000 in debt, with a net cash position of 48.89 million or 0.37 per share.

Cash & Cash Equivalents	49.86M
Total Debt	970,000
Net Cash	48.89M
Net Cash Per Share	0.37
Equity (Book Value)	99.47M
Book Value Per Share	0.78
Working Capital	41.54M

Cash Flow

In the last 12 months, operating cash flow was -72.25 million and capital expenditures -57,000, giving a free cash flow of -72.31 million.

Operating Cash Flow	-72.25M
Capital Expenditures	-57,000
Depreciation & Amortization	21,000
Net Borrowing	-20.81M
Free Cash Flow	-72.31M
FCF Per Share	-0.54

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:ACE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-110.07%
Shareholder Yield	-110.07%
Earnings Yield	-18.94%
FCF Yield	-17.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2